
John D. Ulm
Examiner (ID: 10769, Phone: (571)272-0880 , Office: P/1649 )
| Most Active Art Unit | 1649 |
| Art Unit(s) | 1649, 1812, 1646, 1805 |
| Total Applications | 2240 |
| Issued Applications | 1195 |
| Pending Applications | 205 |
| Abandoned Applications | 843 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7628077
[patent_doc_number] => 06806359
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-10-19
[patent_title] => 'Hormone receptor compositions and methods'
[patent_app_type] => B1
[patent_app_number] => 08/464574
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 79
[patent_figures_cnt] => 95
[patent_no_of_words] => 46694
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/806/06806359.pdf
[firstpage_image] =>[orig_patent_app_number] => 08464574
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/464574 | Hormone receptor compositions and methods | Jun 4, 1995 | Issued |
Array
(
[id] => 6715897
[patent_doc_number] => 20030027245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-06
[patent_title] => 'HUMAN G-PROTEIN COUPLED RECEPTOR'
[patent_app_type] => new
[patent_app_number] => 08/462314
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13346
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20030027245.pdf
[firstpage_image] =>[orig_patent_app_number] => 08462314
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/462314 | HUMAN G-PROTEIN COUPLED RECEPTOR | Jun 4, 1995 | Abandoned |
Array
(
[id] => 4205977
[patent_doc_number] => 06027933
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-22
[patent_title] => 'Surface expression libraries of heteromeric receptors'
[patent_app_type] => 1
[patent_app_number] => 8/470297
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 19804
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/027/06027933.pdf
[firstpage_image] =>[orig_patent_app_number] => 470297
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/470297 | Surface expression libraries of heteromeric receptors | Jun 4, 1995 | Issued |
Array
(
[id] => 4200793
[patent_doc_number] => 06013766
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-01-11
[patent_title] => 'Cloning and expression of a novel acetylcholine-gated ion channel receptor subunit'
[patent_app_type] => 1
[patent_app_number] => 8/464258
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 23
[patent_no_of_words] => 18475
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/013/06013766.pdf
[firstpage_image] =>[orig_patent_app_number] => 464258
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/464258 | Cloning and expression of a novel acetylcholine-gated ion channel receptor subunit | Jun 4, 1995 | Issued |
Array
(
[id] => 3838226
[patent_doc_number] => 05744348
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-28
[patent_title] => 'TSH receptor'
[patent_app_type] => 1
[patent_app_number] => 8/459107
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 18
[patent_no_of_words] => 4430
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/744/05744348.pdf
[firstpage_image] =>[orig_patent_app_number] => 459107
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/459107 | TSH receptor | Jun 1, 1995 | Issued |
Array
(
[id] => 3626275
[patent_doc_number] => 05686281
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-11-11
[patent_title] => 'Chimeric receptor molecules for delivery of co-stimulatory signals'
[patent_app_type] => 1
[patent_app_number] => 8/455860
[patent_app_country] => US
[patent_app_date] => 1995-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 15017
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/686/05686281.pdf
[firstpage_image] =>[orig_patent_app_number] => 455860
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/455860 | Chimeric receptor molecules for delivery of co-stimulatory signals | May 30, 1995 | Issued |
Array
(
[id] => 3882080
[patent_doc_number] => 05714147
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-02-03
[patent_title] => 'Hybrid immunoglobulins'
[patent_app_type] => 1
[patent_app_number] => 8/451848
[patent_app_country] => US
[patent_app_date] => 1995-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 14
[patent_no_of_words] => 24745
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/714/05714147.pdf
[firstpage_image] =>[orig_patent_app_number] => 451848
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/451848 | Hybrid immunoglobulins | May 25, 1995 | Issued |
Array
(
[id] => 4370111
[patent_doc_number] => 06274706
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-14
[patent_title] => 'Intron/exon of the human and mouse beta 3-adrenergic receptor genes'
[patent_app_type] => 1
[patent_app_number] => 8/450962
[patent_app_country] => US
[patent_app_date] => 1995-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 10357
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/274/06274706.pdf
[firstpage_image] =>[orig_patent_app_number] => 450962
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/450962 | Intron/exon of the human and mouse beta 3-adrenergic receptor genes | May 24, 1995 | Issued |
Array
(
[id] => 3759415
[patent_doc_number] => 05741667
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-21
[patent_title] => 'Tumor necrosis factor receptor-associated factors'
[patent_app_type] => 1
[patent_app_number] => 8/446915
[patent_app_country] => US
[patent_app_date] => 1995-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 29
[patent_no_of_words] => 38121
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/741/05741667.pdf
[firstpage_image] =>[orig_patent_app_number] => 446915
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/446915 | Tumor necrosis factor receptor-associated factors | May 21, 1995 | Issued |
Array
(
[id] => 1418198
[patent_doc_number] => 06521740
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-18
[patent_title] => 'Type II Interleukin-1 receptors'
[patent_app_type] => B1
[patent_app_number] => 08/441893
[patent_app_country] => US
[patent_app_date] => 1995-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 21178
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/521/06521740.pdf
[firstpage_image] =>[orig_patent_app_number] => 08441893
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/441893 | Type II Interleukin-1 receptors | May 15, 1995 | Issued |
Array
(
[id] => 3850350
[patent_doc_number] => 05767064
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-16
[patent_title] => 'Soluble type II interleukin-1 receptors and methods'
[patent_app_type] => 1
[patent_app_number] => 8/442043
[patent_app_country] => US
[patent_app_date] => 1995-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17887
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/767/05767064.pdf
[firstpage_image] =>[orig_patent_app_number] => 442043
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/442043 | Soluble type II interleukin-1 receptors and methods | May 15, 1995 | Issued |
Array
(
[id] => 3827780
[patent_doc_number] => 05739029
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-14
[patent_title] => 'Vectors for expression of G protein coupled receptors in yeast'
[patent_app_type] => 1
[patent_app_number] => 8/441291
[patent_app_country] => US
[patent_app_date] => 1995-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 5239
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/739/05739029.pdf
[firstpage_image] =>[orig_patent_app_number] => 441291
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/441291 | Vectors for expression of G protein coupled receptors in yeast | May 14, 1995 | Issued |
Array
(
[id] => 3848220
[patent_doc_number] => 05766923
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-16
[patent_title] => 'Isolated nucleic acid encoding ligands for FGFR'
[patent_app_type] => 1
[patent_app_number] => 8/441629
[patent_app_country] => US
[patent_app_date] => 1995-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 17
[patent_no_of_words] => 11302
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/766/05766923.pdf
[firstpage_image] =>[orig_patent_app_number] => 441629
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/441629 | Isolated nucleic acid encoding ligands for FGFR | May 14, 1995 | Issued |
Array
(
[id] => 1549774
[patent_doc_number] => 06399313
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-04
[patent_title] => 'AMPA-binding human GluR2 receptors'
[patent_app_type] => B1
[patent_app_number] => 08/439946
[patent_app_country] => US
[patent_app_date] => 1995-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 7398
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/399/06399313.pdf
[firstpage_image] =>[orig_patent_app_number] => 08439946
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/439946 | AMPA-binding human GluR2 receptors | May 11, 1995 | Issued |
Array
(
[id] => 3600753
[patent_doc_number] => 05578464
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-11-26
[patent_title] => 'E. coli secretory strains'
[patent_app_type] => 1
[patent_app_number] => 8/438803
[patent_app_country] => US
[patent_app_date] => 1995-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9370
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/578/05578464.pdf
[firstpage_image] =>[orig_patent_app_number] => 438803
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/438803 | E. coli secretory strains | May 10, 1995 | Issued |
| 08/438259 | METHODS OF PREPARING SOLUBLE, OLIGOMERIC PROTEINS | May 9, 1995 | Abandoned |
Array
(
[id] => 4041154
[patent_doc_number] => 05874264
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-23
[patent_title] => 'Gibbon ape leukemia virus receptor'
[patent_app_type] => 1
[patent_app_number] => 8/436900
[patent_app_country] => US
[patent_app_date] => 1995-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 20
[patent_no_of_words] => 7882
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/874/05874264.pdf
[firstpage_image] =>[orig_patent_app_number] => 436900
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/436900 | Gibbon ape leukemia virus receptor | May 7, 1995 | Issued |
Array
(
[id] => 3727284
[patent_doc_number] => 05652111
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-29
[patent_title] => 'Binding assay utilizing a nucleic acid encoding apamin binding protein'
[patent_app_type] => 1
[patent_app_number] => 8/436716
[patent_app_country] => US
[patent_app_date] => 1995-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 5918
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/652/05652111.pdf
[firstpage_image] =>[orig_patent_app_number] => 436716
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/436716 | Binding assay utilizing a nucleic acid encoding apamin binding protein | May 7, 1995 | Issued |
Array
(
[id] => 3756757
[patent_doc_number] => 05721132
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-02-24
[patent_title] => 'Synthetic gene for D4 dopamine receptors'
[patent_app_type] => 1
[patent_app_number] => 8/434877
[patent_app_country] => US
[patent_app_date] => 1995-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 5675
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/721/05721132.pdf
[firstpage_image] =>[orig_patent_app_number] => 434877
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/434877 | Synthetic gene for D4 dopamine receptors | May 2, 1995 | Issued |
Array
(
[id] => 1546386
[patent_doc_number] => 06444789
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-03
[patent_title] => 'CD16-II variants'
[patent_app_type] => B1
[patent_app_number] => 08/433123
[patent_app_country] => US
[patent_app_date] => 1995-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8716
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/444/06444789.pdf
[firstpage_image] =>[orig_patent_app_number] => 08433123
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/433123 | CD16-II variants | May 2, 1995 | Issued |